Clase had quite a bit of hype last offseason for a reliever with just 21 games and one save to his name. Those who hoped to see him surpass Brad Hand as closer wound up rather disappointed, as he tested positive for Boldenone, a performance-enhancing drug, leading to a year-long suspension. It was already shaping up to be a rocky season for the young righty, as a strained lat in late February would have seen him miss the first few months of the season under ordinary circumstances. We're now left with a player who has plenty of potential but who hasn't pitched in over a year and has recently battled an arm injury. That's a risky proposition, but the upside is still there and Hand is now out the door, opening up save chances. That keeps Clase firmly in lottery-ticket territory, though his 22.3 K% as a rookie and 23.7 K% in the minors mean he may not provide much value if he doesn't get saves. Read Past Outlooks